FDA Consumer Health Information
Medication Safety: Advice for New Moms
What to Know When Buying or Using a Breast Pump
Breast pumps are medical devices regulated by the U.S. Food and Drug Administration. But to protect mothers and their babies, there are important safety considerations to know before using one. Read the Consumer Update for answers to five key questions.May 9, 2017
Spotlight on CDER Science: Modernizing the Way Drugs Are Made: A Transition to Continuous Manufacturing
C.O. Truxton, Inc. Issues Voluntary Nationwide Recall of Amitriptyline HCL Tablets, USP 50mg and Phenobarbital Tablets, USP 15mg, 30mg, 60mg, 100mg Due to Potential Label Mix-Up
Drug Approval Packages
Ocrevus (ocrelizumab) Injection
Drug Firm Annual Registration Status (updated)
Drug Firm Annual Registration Status Download File (updated)
Drug Trials Snapshots: RYDAPT
La FDA aprueba cambios en la etiqueta para el uso de anestésicos generales y sedantes en niños pequeños
National Drug Code Directory
Wholesale Distributor and Third-Party Logistics Providers Reporting(updated)
New and Generic Drug Approvals
May 9, 2017
Drug Name and
Application NumberActive IngredientDosage Form/ RouteSubmissionCompanySubmission ClassificationSubmission StatusBavencio
BLA #761078 Avelumab Injectable; Intravenous ORIG-1 Emd Serono Inc Type 1 - New Molecular Entity Approved
Showing 1 to 1 of 1 entries
May 8, 2017
Drug Name and
Application NumberActive IngredientDosage Form/ RouteSubmissionCompanySubmission ClassificationSubmission StatusArestin
NDA #050781 Minocycline Hydrochloride Powder, Extended Release; Dental SUPPL-20 Orapharma Labeling Approved
Bactroban
NDA #050591 Mupirocin Ointment; Topical SUPPL-34 Glaxosmithkline Labeling Approved
Bactroban
NDA #050703 Mupirocin Calcium Ointment; Nasal SUPPL-17 Glaxosmithkline Labeling Approved
Bactroban
NDA #050746 Mupirocin Calcium Cream; Topical SUPPL-21 Glaxosmithkline Labeling Approved
Epivir-Hbv
NDA #021003 Lamivudine Tablet; Oral SUPPL-16 Glaxosmithkline Labeling Approved
Epivir-Hbv
NDA #021004 Lamivudine Solution; Oral SUPPL-16 Glaxosmithkline Labeling Approved
Indomethacin
ANDA #204853 Indomethacin Capsule, Extended Release; Oral ORIG-1 Novast Labs Ltd Approved
Minolira
NDA #209269 Minocycline Hydrochloride Tablet, Extended Release; Oral ORIG-1 Dr Reddys Labs Ltd Type 5 - New Formulation or New Manufacturer Approved
Norgestrel and Ethinyl Estradiol
ANDA #202875 Ethinyl Estradiol; Norgestrel Tablet; Oral-28 ORIG-1 Mylan Labs Ltd Approved
Novolog Mix 70/30 Flexpen
NDA #021172 Insulin Aspart Protamine Recombinant; Insulin Aspart Recombinant Injectable; Subcutaneous SUPPL-62 Novo Nordisk Inc Labeling Approved
Novolog Mix 70/30
NDA #021172 Insulin Aspart Protamine Recombinant; Insulin Aspart Recombinant Injectable; Subcutaneous SUPPL-62 Novo Nordisk Inc Labeling Approved
Novolog Mix 70/30 Penfill
NDA #021172 Insulin Aspart Protamine Recombinant; Insulin Aspart Recombinant Injectable; Subcutaneous SUPPL-62 Novo Nordisk Inc Labeling Approved
Purixan
NDA #205919 Mercaptopurine Suspension; Oral SUPPL-2 Nova Labs Ltd Labeling Approved
Purixan
NDA #205919 Mercaptopurine Suspension; Oral SUPPL-2 Nova Labs Ltd Labeling Approved
Purixan
NDA #205919 Mercaptopurine Suspension; Oral SUPPL-2 Nova Labs Ltd Labeling Approved
Saizen
NDA #019764 Somatropin Recombinant Injectable; Injection SUPPL-86 Emd Serono Labeling Approved
Saizen
NDA #019764 Somatropin Recombinant Injectable; Injection SUPPL-86 Emd Serono Labeling Approved
Sodium Phenylacetate and Sodium Benzoate
ANDA #208521 Sodium Benzoate; Sodium Phenylacetate Solution; Iv (Infusion) ORIG-1 Maia Pharms Inc
